Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination.
measles
subacute sclerosing panencephalitis
treatment
vaccination
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
31 03 2022
31 03 2022
Historique:
received:
31
01
2022
revised:
23
03
2022
accepted:
24
03
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
27
4
2022
Statut:
epublish
Résumé
Subacute sclerosing panencephalitis (SSPE) is a late complication of measles virus infection that occurs in previously healthy children. This disease has no specific cure and is associated with a high degree of disability and mortality. In recent years, there has been an increase in its incidence in relation to a reduction in vaccination adherence, accentuated by the COVID-19 pandemic. In this article, we take stock of the current evidence on SSPE and report our personal clinical experience. We emphasise that, to date, the only effective protection strategy against this disease is vaccination against the measles virus.
Identifiants
pubmed: 35458463
pii: v14040733
doi: 10.3390/v14040733
pmc: PMC9029616
pii:
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Références
Neurology. 2004 Feb 10;62(3):457-60
pubmed: 14872030
JAMA. 1969 Mar 24;207(12):2248-54
pubmed: 5818397
Virology. 1992 Jun;188(2):910-5
pubmed: 1585658
J Pediatr. 2001 Jun;138(6):926-8
pubmed: 11391343
Brain Dev. 1989;11(5):308-12
pubmed: 2479277
J Infect Dis. 2002 May 1;185(9):1346-50
pubmed: 12001055
Clin Chem. 1991 Jul;37(7):1153-60
pubmed: 1855284
Eur J Paediatr Neurol. 2014 Jul;18(4):536-9
pubmed: 24679544
J Virol. 2021 Jun 24;95(14):e0052821
pubmed: 33910952
Brain Dev. 1993 Sep-Oct;15(5):346-55
pubmed: 7506498
Nat Med. 2021 Mar;27(3):360-361
pubmed: 33589823
Nat Commun. 2012;3:1235
pubmed: 23212364
J Virol. 2007 Jul;81(13):6827-36
pubmed: 17442724
J Child Neurol. 2003 Dec;18(12):819-27
pubmed: 14736075
Lancet. 1982 May 8;1(8280):1034-7
pubmed: 6176821
Rev Med Virol. 2019 Sep;29(5):e2058
pubmed: 31237061
J Virol. 2019 Feb 5;93(4):
pubmed: 30487282
Dev Med Child Neurol. 2019 Oct;61(10):1139-1144
pubmed: 30680706
J Child Neurol. 2007 Mar;22(3):341-3
pubmed: 17621509
J Cell Sci. 2019 Aug 23;132(16):
pubmed: 31331966
Virus Genes. 2007 Aug;35(1):17-27
pubmed: 17039408
Antimicrob Agents Chemother. 2001 Mar;45(3):943-5
pubmed: 11181386
Brain Dev. 2003 Oct;25(7):514-7
pubmed: 13129596
MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34
pubmed: 23760231
J Gen Virol. 1995 May;76 ( Pt 5):1173-80
pubmed: 7730801
J Exp Med. 2005 Nov 7;202(9):1185-90
pubmed: 16260490
J Neuropathol Exp Neurol. 1996 Apr;55(4):471-80
pubmed: 8786407
J Virol. 2015 Mar;89(5):2710-7
pubmed: 25520515
J Virol. 2018 Feb 26;92(6):
pubmed: 29298883
MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1700-1705
pubmed: 33180759
Cochrane Database Syst Rev. 2014 Apr 01;(4):CD010056
pubmed: 24687262
Clin Infect Dis. 2017 Nov 13;65(11):1843-1847
pubmed: 29028959
Euro Surveill. 2020 May;25(19):
pubmed: 32431288
J Clin Virol. 2015 Mar;64:34-9
pubmed: 25728076
Molecules. 2021 Jan 15;26(2):
pubmed: 33467470
Cochrane Database Syst Rev. 2001;(2):CD001479
pubmed: 11405993
J Virol. 2013 Mar;87(5):2648-59
pubmed: 23255801
J Child Neurol. 2003 Feb;18(2):104-8
pubmed: 12693776
Ann Neurol. 1980 Feb;7(2):185-8
pubmed: 6154441
Viruses. 2019 Nov 02;11(11):
pubmed: 31684034
Int J Epidemiol. 2007 Dec;36(6):1334-48
pubmed: 18037676
Adv Ther. 2019 Aug;36(8):1878-1905
pubmed: 31168764
Virology. 1993 Nov;197(1):188-95
pubmed: 8212553
Wkly Epidemiol Rec. 2003 Jul 4;78(27):229-32
pubmed: 12866261
Lancet. 2022 Feb 12;399(10325):678-690
pubmed: 35093206
Ann Ist Super Sanita. 2017 Apr-Jun;53(2):167-169
pubmed: 28617265
Virology. 2007 May 25;362(1):235-44
pubmed: 17434199
Virus Res. 2002 Jun;86(1-2):123-31
pubmed: 12076836
Ann Neurol. 1982 Apr;11(4):359-64
pubmed: 6179455
Arch Virol. 2001;146(4):815-23
pubmed: 11402867
Pediatric Health Med Ther. 2018 Jun 26;9:67-71
pubmed: 29985487
Antimicrob Agents Chemother. 2004 Dec;48(12):4631-5
pubmed: 15561836
Emerg Infect Dis. 2003 Oct;9(10):1333-6
pubmed: 14609476
Pediatr Neurol. 2001 Jan;24(1):54-9
pubmed: 11182282
J Virol. 1998 Feb;72(2):1224-34
pubmed: 9445022
J Neurovirol. 2002 Feb;8(1):24-34
pubmed: 11847589
Korean J Pediatr. 2019 Mar;62(3):108-112
pubmed: 30304904
Adv Virol. 2015;2015:769837
pubmed: 26587021
Trends Microbiol. 2019 Feb;27(2):164-175
pubmed: 30220445
Antiviral Res. 1998 Jan;37(1):29-35
pubmed: 9497070
J Virol. 2022 Feb 9;96(3):e0194921
pubmed: 34788082
Pediatr Infect Dis J. 2011 Jan;30(1):78-80
pubmed: 20844460
N Engl J Med. 1998 May 14;338(20):1448-56
pubmed: 9583972
Neurology. 1997 Feb;48(2):526-8
pubmed: 9040751
Clin Ther. 2004 Nov;26(11):1890-4
pubmed: 15639700
J Virol. 2000 Feb;74(4):1908-18
pubmed: 10644364
Hum Vaccin Immunother. 2019;15(9):2060-2065
pubmed: 31116633
Dev Med Child Neurol. 2010 Oct;52(10):901-7
pubmed: 20561004
Clin Infect Dis. 1993 May;16(5):654-60
pubmed: 8323578
J Neuroimmunol. 2007 Jul;187(1-2):139-46
pubmed: 17512988
Acta Neuropathol. 1982;56(1):52-62
pubmed: 7039211
Arch Neurol. 2002 May;59(5):822-7
pubmed: 12020266
JAMA. 2020 Oct 6;324(13):1344-1345
pubmed: 32797149
Int J Epidemiol. 1992 Oct;21(5):998-1006
pubmed: 1468866
Clin Microbiol Infect. 2021 Feb;27(2):289.e5-289.e7
pubmed: 33161149
mBio. 2021 Jun 29;12(3):e0079921
pubmed: 34061592
Pediatr Infect Dis J. 2019 May;38(5):496-499
pubmed: 30153227